Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accidents will happen

John A Lee1

  • 1Department of Histopathology, Rotherham General Hospital, Rotherham S60 2UD, UK.

The Lancet. Oncology
|February 6, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric threshold.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Scalable, memory-efficient robust proton therapy optimization through beamlet-free treatment planning.

Medical physics·2025
Same author

Dynamic proton arc treatment planning study for oesophageal cancer.

Physics and imaging in radiation oncology·2025
Same author

Towards faster plan adaptation for proton arc therapy using initial treatment plan information.

Physics and imaging in radiation oncology·2025
Same author

Anticipating potential bottlenecks in adaptive proton FLASH therapy: a ridge filter reuse strategy.

Physics in medicine and biology·2025
Same author

Proton arc therapy plan optimization with energy layer pre-selection driven by organ at risk sparing and delivery time.

Physics in medicine and biology·2025
Same journal

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

The Lancet. Oncology·2026
Same journal

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026
Same journal

Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

The Lancet. Oncology·2026
Same journal

European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

The Lancet. Oncology·2026
Same journal

Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.

The Lancet. Oncology·2026
Same journal

Correction to Lancet Oncol 2025; 26: e369-80.

The Lancet. Oncology·2026
See all related articles